Skip to main content

Western blot in homogenised mouse brain samples

Retaining all 28 original steps and buffer recipes. CALB1 and beta-actin are the authors’ examples, not APP detection parameters or validation in the target AD strains. CALB1 and the conjugated beta-actin antibody remain the source authors’ examples, not APP detection parameters.

Scope and method

Sample:Mouse brain homogenate; unilateral striatum in the original source

Reagents and materials from the source protocol

StepMaterialRoleAmountRequired / optionalSKU / specification
Preparing SamplesDry ice for brain tissue RNA extraction preparationDry ice · Dry iceRequired
Preparing SamplesOriginal-source RIPA bufferOriginal-source RIPA buffer · Original-source RIPA buffer200 µL per unilateral striatum; 50 mM Tris pH8 (0.606 g/100ml), 150 mM NaCl (0.877 g/100ml), 1% NP-40, 0.5% NaDeoxycholate, 0.1% SDS; per 10 mL add 1x protease inhibitor cocktail tablet and 1x PhosSTOP tabletRequired
Preparing SamplesTissue homogenizerTissue homogenizer · Tissue TearorRequired
Preparing SamplesRefrigerated centrifugeRefrigerated centrifuge · Refrigerated centrifuge4°C; 6g; 5 minRequired
Analysing Protein ConcentrationBovine serum albumin (BSA, Fraction V)BSA standards · BSA standards1.0/0.8/0.6/0.4/0.2/0.0 mg/mLRequired
Analysing Protein ConcentrationBicinchoninic acid solutionBicinchoninic acid solution · Bicinchoninic acid solution16 mLRequired
Analysing Protein ConcentrationCopper (II) sulfate solutionCopper (II) sulfate solution · Copper (II) sulfate solution320 µLRequired
Analysing Protein ConcentrationProtein quantification well plateProtein quantification well plate · Protein quantification well plate10 µL sample/standard + 100 µL solution A; triplicateRequired
Analysing Protein ConcentrationPlate covering filmPlate covering film · Plate covering filmRequired
Analysing Protein ConcentrationSpectrophotometerSpectrophotometer · Spectrophotometer562 nmRequired
Running Western Electrophoresis Gel6x loading buffer6x loading buffer · 6x loading buffer17 µL per 83 µL sample; 12% SDS (1.2g/10 ml), 30% beta-mercaptoethanol, 60% glycerol, 0.012% Bromophenol blue, 375 mM Tris pH6.8Required
Running Western Electrophoresis GelPrecast gel cassettesPrecast gel cassettes · Precast gel cassettes4–12%Required
Running Western Electrophoresis Gel10x running buffer10x running buffer · 10x running bufferPer 1 L: 144g glycine, 30.3g Tris base, 10g SDS, MilliQ to 1 L; use at 1XRequired
Running Western Electrophoresis GelDevelopable ladderDevelopable ladder · Last laneRequired
Running Western Electrophoresis GelVisible and developable ladderVisible and developable ladder · First laneRequired
Running Western Electrophoresis GelElectrophoresis machineElectrophoresis machine · Electrophoresis machine200V/100mA; 60 minRequired
Running Western Electrophoresis Gel10x transfer buffer and 1x working solution10x transfer buffer and 1x working solution · 10x transfer buffer and 1x working solution10x per 1 L: 144g glycine, 30.3g Tris base; 1x: 750 mL dH2O + 150 mL MetOH + 100 mL 10xRequired
Running Western Electrophoresis GelTransfer machineTransfer machine · Transfer machineRequired
Running Western Electrophoresis GelTransfer membraneTransfer membrane · Transfer membraneRequired
Running Antibodies10x TBS and TBST10x TBS and TBST · 10x TBS and TBST10x per 1 L: 200 mL 1 M Tris pH7.5, 80g NaCl, MilliQ to 1 L; add Triton at 1% for TBSTRequired
Running AntibodiesTBST/milk antibody diluentTBST/milk antibody diluent · TBST/milk antibody diluent50 mL TBST with 4% dried milk; 3 mL for incubationRequired
Running AntibodiesAnti-Calbindin D-28k antibodyCALB1 primary antibody (authors’ example) · Cell Signaling #13176; not an APP parameter1:1000RequiredREF-cell-signaling-technology-13176
Running Antibodies50 mL conical tube50 mL conical tube · 50 mL conical tube50 mLRequired
Running AntibodiesHRP-conjugated secondary antibodyHRP-conjugated secondary antibody · HRP-conjugated secondary antibody1:3000Required
Running AntibodiesECL chemiluminescent substrateChemiluminescent ECL substrate kit · Chemiluminescent ECL substrate kitAbout 1 mL of each componentRequired
Running AntibodiesGel Doc systemGel Doc system · Gel Doc systemRequired
Running AntibodiesAnti-beta-actin antibodyConjugated beta-actin antibody · The source’s already conjugated 1º/2º antibody1:50000Required
Inquire about the whole BOM

Bulk pricing and availability inquiry

Submitting an inquiry does not place an order or confirm a purchase.

Protocol #209 · revision 4 Dry ice for brain tissue RNA extraction preparation | | Available for inquiry Original-source RIPA buffer | 200 µL per unilateral striatum; 50 mM Tris pH8 (0.606 g/100ml), 150 mM NaCl (0.877 g/100ml), 1% NP-40, 0.5% NaDeoxycholate, 0.1% SDS; per 10 mL add 1x protease inhibitor cocktail tablet and 1x PhosSTOP tablet | Available for inquiry Tissue homogenizer | | Available for inquiry Refrigerated centrifuge | 4°C; 6g; 5 min | Available for inquiry Bovine serum albumin (BSA, Fraction V) | 1.0/0.8/0.6/0.4/0.2/0.0 mg/mL | Available for inquiry Bicinchoninic acid solution | 16 mL | Available for inquiry Copper (II) sulfate solution | 320 µL | Available for inquiry Protein quantification well plate | 10 µL sample/standard + 100 µL solution A; triplicate | Available for inquiry Plate covering film | | Available for inquiry Spectrophotometer | 562 nm | Available for inquiry 6x loading buffer | 17 µL per 83 µL sample; 12% SDS (1.2g/10 ml), 30% beta-mercaptoethanol, 60% glycerol, 0.012% Bromophenol blue, 375 mM Tris pH6.8 | Available for inquiry Precast gel cassettes | 4–12% | Available for inquiry 10x running buffer | Per 1 L: 144g glycine, 30.3g Tris base, 10g SDS, MilliQ to 1 L; use at 1X | Available for inquiry Developable ladder | | Available for inquiry Visible and developable ladder | | Available for inquiry Electrophoresis machine | 200V/100mA; 60 min | Available for inquiry 10x transfer buffer and 1x working solution | 10x per 1 L: 144g glycine, 30.3g Tris base; 1x: 750 mL dH2O + 150 mL MetOH + 100 mL 10x | Available for inquiry Transfer machine | | Available for inquiry Transfer membrane | | Available for inquiry 10x TBS and TBST | 10x per 1 L: 200 mL 1 M Tris pH7.5, 80g NaCl, MilliQ to 1 L; add Triton at 1% for TBST | Available for inquiry TBST/milk antibody diluent | 50 mL TBST with 4% dried milk; 3 mL for incubation | Available for inquiry Anti-Calbindin D-28k antibody | 1:1000 | REF-cell-signaling-technology-13176 50 mL conical tube | 50 mL | Available for inquiry HRP-conjugated secondary antibody | 1:3000 | Available for inquiry ECL chemiluminescent substrate | About 1 mL of each component | Available for inquiry Gel Doc system | | Available for inquiry Anti-beta-actin antibody | 1:50000 | Available for inquiry

Matched reagent selection

This reagent table is a selection table, not experimental steps. Supplier application evidence is not validation in this model. No source dilution is assigned to these selected products.

APP C-terminal

Model readout evidence
  1. Jie Liu · 2014 · Channels
  2. Barbara Bettegazzi · 2021 · Cell Death and Disease
Product / same-code ERP ItemRolesSupplier attributesSource steps
Abcam ab32136

REF-abcam-ab32136

Used in 26 studies that performed Western blot on mouse samples
  1. Yasir H. Qureshi · 2022 · Cell Reports · Span-bound evidence
  2. Guoxin Zhang · 2024 · Aging Cell · Span-bound evidence
  3. Lindsay A. Hohsfield · 2015 · PLoS ONE · Paper-level evidence
  4. Yangmei Huang · 2018 · Journal of Alzheimer s Disease · Paper-level evidence
  5. Chunyue Wang · 2018 · International Journal of Molecular Medicine · Paper-level evidence
  6. Rachel E. Lackie · 2020 · Acta Neuropathologica Communications · Paper-level evidence
  7. Nuno Santos Leal · 2020 · Cells · Paper-level evidence
  8. Zhiping Li · 2020 · Molecular Medicine Reports · Paper-level evidence
  9. Tingting Pi · 2021 · Behavioural Neurology · Paper-level evidence
  10. Megan K. Elder · 2021 · Communications Biology · Paper-level evidence
  11. Harpreet Kaur · 2021 · International Journal of Molecular Sciences · Paper-level evidence
  12. Lulin Nie · 2021 · Aging · Paper-level evidence
  13. Jiuyang Ding · 2021 · Oxidative Medicine and Cellular Longevity · Paper-level evidence
  14. Anna Mietelska‐Porowska · 2022 · International Journal of Molecular Sciences · Paper-level evidence
  15. Yaling Jiang · 2022 · Advanced Science · Paper-level evidence
  16. Yutong Shang · 2022 · Acta Neuropathologica · Paper-level evidence
  17. Lizhen Cheng · 2023 · Cell Communication and Signaling · Paper-level evidence
  18. Wen Li · 2023 · BMC Medicine · Paper-level evidence
  19. Junhua Li · 2023 · CNS Neuroscience & Therapeutics · Paper-level evidence
  20. Shuyi Wang · 2023 · International Journal of Molecular Sciences · Paper-level evidence
  21. Rikesh M. Rajani · 2024 · PLoS Biology · Paper-level evidence
  22. Anika Perdok · 2024 · Nature Communications · Paper-level evidence
  23. Yan‐Yan Xue · 2024 · Translational Neurodegeneration · Paper-level evidence
  24. Zhuoze Wu · 2025 · Neuroscience Bulletin · Paper-level evidence
  25. Jingjing Zhang · 2025 · Alzheimer s Research & Therapy · Paper-level evidence
  26. Barbara Plagg · 2015 · Biogerontology · Paper-level evidence
Primary antibodyHost: rabbit · IgG · Reactivity: mouse, rat, human · Western blot / Tissue lysate · IHC / IF / paraffin Supplier source20
Cell Signaling Technology 7074

REF-cell-signaling-technology-7074

Secondary antibodyHost: goat · Reactivity: rabbit · IgG H+L · HRP · Western blot / Tissue lysate Supplier source23
Thermo Fisher Scientific 15568025

REF-thermo-fisher-scientific-15568025

Lysis component Supplier source2
Sigma-Aldrich G5516

REF-sigma-aldrich-g5516

Loading component Supplier source11
Sigma-Aldrich T8787

REF-sigma-aldrich-t8787

Wash component · Blocking component · Primary diluent component · Secondary diluent component Supplier source18, 22, 24, 19, 20, 23
Sigma-Aldrich A8717

REF-sigma-aldrich-a8717

Alternative primary antibody

Used in 36 studies that performed Western blot on mouse samples
  1. Takahiro Morito · 2025 · Journal of Neuroscience · Span-bound evidence
  2. Stefan Prokop · 2015 · The Journal of Experimental Medicine · Paper-level evidence
  3. Mikko O. Hiltunen · 2011 · Journal of Cellular and Molecular Medicine · Paper-level evidence
  4. Raquel Maria Sanchez-Varo · 2011 · Acta Neuropathologica · Paper-level evidence
  5. Ye Ji Jeong · 2015 · Current Alzheimer Research · Paper-level evidence
  6. Qi Wang · 2014 · Disease Models & Mechanisms · Paper-level evidence
  7. Tae‐Shin Park · 2016 · International Journal of Molecular Medicine · Paper-level evidence
  8. Lisa K. Wagner · 2017 · Acta Neuropathologica Communications · Paper-level evidence
  9. Qi Shi · 2017 · Scientific Reports · Paper-level evidence
  10. Caterina Branca · 2017 · Aging Cell · Paper-level evidence
  11. Frank Raven · 2017 · EBioMedicine · Paper-level evidence
  12. Marta Pera · 2017 · The EMBO Journal · Paper-level evidence
  13. Yangmei Huang · 2018 · Journal of Alzheimer s Disease · Paper-level evidence
  14. Joseph Flores · 2018 · Nature Communications · Paper-level evidence
  15. Qingyuan Fan · 2019 · The Journal of Experimental Medicine · Paper-level evidence
  16. Alexander R. Pilozzi · 2020 · Biomolecules · Paper-level evidence
  17. Weixi Feng · 2020 · Alzheimer s Research & Therapy · Paper-level evidence
  18. Maa O. Quartey · 2021 · Scientific Reports · Paper-level evidence
  19. Qiang Su · 2021 · Alzheimer s Research & Therapy · Paper-level evidence
  20. Ni-Ya Wang · 2021 · Neurotherapeutics · Paper-level evidence
  21. Chang F. Qu · 2021 · Journal of Advanced Research · Paper-level evidence
  22. Jihoon Han · 2021 · Theranostics · Paper-level evidence
  23. Keliang Pang · 2021 · Cell Research · Paper-level evidence
  24. Yuanyuan Zhao · 2022 · Nature Communications · Paper-level evidence
  25. De‐Juan Yuan · 2022 · Aging Cell · Paper-level evidence
  26. Ju‐Hyun Lee · 2022 · Nature Neuroscience · Paper-level evidence
  27. Marcella Catania · 2022 · Molecular Psychiatry · Paper-level evidence
  28. Yutong Shang · 2022 · Acta Neuropathologica · Paper-level evidence
  29. Hanseul Park · 2022 · Translational Neurodegeneration · Paper-level evidence
  30. Joseph Flores · 2022 · Cell Death and Disease · Paper-level evidence
  31. Qingqing Xu · 2023 · Journal of Neuroinflammation · Paper-level evidence
  32. Marta Carús-Cadavieco · 2023 · Life Science Alliance · Paper-level evidence
  33. Akihiro Ishii · 2024 · Molecular Neurodegeneration · Paper-level evidence
  34. Margareta Kurkela · 2025 · Journal of Biological Chemistry · Paper-level evidence
  35. Lu Wang · 2025 · Nature Communications · Paper-level evidence
  36. Kalyani Chaubey · 2025 · Cell Reports Medicine · Paper-level evidence
Primary antibodyHost: rabbit · IgG · Reactivity: mouse, rat, human · unconjugated · Western blot / Tissue lysate · IHC / IF / paraffin Supplier source20

Original source procedure

  1. Preparing Samples

    Take samples out of the -80°C freezer and keep on dry ice until ready to digest.

  2. Preparing Samples

    On wet ice, add 200 µL RIPA Buffer (see **Materials**) to each unilateral striatum sample.

  3. Preparing Samples

    Mix thoroughly until sample completely blended with Tissue Tearor.

  4. Preparing Samples

    Centrifuge samples at 6g for 5 min at 4ºC.

  5. Preparing Samples

    Using the supernatant, dilute samples to about 1:10 to determine protein concentration.

  6. Analysing Protein Concentration

    **Prepare pre-diluted/standards:** 1.0, 0.8, 0.6, 0.4, 0.2 and 0.0 mg/mL of Bovine Serum Albumin (BSA)

  7. Analysing Protein Concentration

    **Prepare solution A: ** 1. 320 µL Copper (II) Sulfate Solution 1. 16 mL Bicinchoninic Acid Solution

  8. Analysing Protein Concentration

    In a well plate, add 10 µL of pre-diluted samples/standards + 100 µL solution A. **Do this in triplicate.**

  9. Analysing Protein Concentration

    Cover plates with film and incubate the samples for 30 min at 37ºC.

  10. Analysing Protein Concentration

    Measure the absorbance of each sample at 562 nm using a spectrophotometer and create a standard curve to determine concentrations.

  11. Running Western Electrophoresis Gel

    Make up 83 µL samples in RIPA Buffer at a concentration of 20 µg/10 µL and then add 17 µL of 6x Loading Buffer (see **Materials**).

  12. Running Western Electrophoresis Gel

    Boil samples at this stage at 95 ºC for 5 min. **Always check antibody data sheet before performing this step.**

  13. Running Western Electrophoresis Gel

    Prepare 1X Running Buffer (see **Materials**) and add the pre-cast gel cassettes (4 – 12%).

  14. Running Western Electrophoresis Gel

    Load 5 µL of sample per well.

  15. Running Western Electrophoresis Gel

    Load visual + developable ladder in first lane, and only developable ladder in last lane.

  16. Running Western Electrophoresis Gel

    Run electrophoresis for 60 min @ 200V/100mA.

  17. Running Western Electrophoresis Gel

    Transfer gel onto membrane and transfer using machine.

  18. Running Antibodies

    Wash membranes with TBST (see **Materials**) for approximately 1 min and repeat 4x.

  19. Running Antibodies

    Make up 50 mL TBST solution with 4% milk (dried powder).

  20. Running Antibodies

    Roll membranes into 50 mL conical with 3 mL of TBST w/ Milk and Primary Antibody. The following primary antibody (working concentration 1:1000) was used in Brimblecombe, K. et al.: anti-calb1 (Cell Signalling #13176). **Primary Antibody Solutions can be re-used several times. **

  21. Running Antibodies

    Incubate overnight at 4 ºC or ~2 hours at room temperature.

  22. Running Antibodies

    Wash membranes with TBST for approximately 1 min and repeat 4x.

  23. Running Antibodies

    Incubate membrane in TBST w/ Milk and Secondary Antibody HRP conjugated (1:3000) for 1 hour at room temperature. **Secondary Antibody Solutions can be re-used several times. **

  24. Running Antibodies

    Wash membranes with TBST for approximately 1 min and repeat 4x.

  25. Running Antibodies

    Develop membranes with the chemiluminescent ECL Substrate Kit (~ 1 mL of each component).

  26. Running Antibodies

    Visualize gel on a Gel Doc System.

  27. Running Antibodies

    Put membrane back into TBST w/ Milk and the 1º/2º β-actin antibody (already conjugated, 1:50000).

  28. Running Antibodies

    Repeat **steps 25 and 26**.

Quality control and readouts

Antibodies must be suitable for western blot; the source recommends knockout tissue when validating novel antibodies. BSA standards and samples are measured in triplicate.

Sample protein concentration determined from the 562 nm standard curve; ECL and Gel Doc images; beta-actin reprobing images.

Study design
Biological replicates come from individual animals; technical replicates from the same animal illustrate reading reliability.

Katherine Brimblecombe; Natalie Connor-Robson; Stephanie J J Cragg · https://www.protocols.io/view/western-blot-in-homogenised-mouse-brain-samples-yxmvm26m5g3p/v2 · v2 · This is an open access protocol distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited · Katherine Brimblecombe; Natalie Connor-Robson; Stephanie J J Cragg. 2024-01-09. Western blot in homogenised mouse brain samples. protocols.io. https://doi.org/10.17504/protocols.io.yxmvm26m5g3p/v2 Version created by Cláudia C Mendes. · 据原版完整步骤作忠实中文翻译;英文保留原文,数值、原生步骤ID及顺序保留。材料用量仅照原文,不作推算。第17步忠实保留原文简略转膜说明,不补程序;第4步6g照原文,不擅改为其他离心力。CALB1条件只属原作者示例。

References

  1. Katherine Brimblecombe; Natalie Connor-Robson; Stephanie J J Cragg. 2024-01-09. Western blot in homogenised mouse brain samples. protocols.io. https://doi.org/10.17504/protocols.io.yxmvm26m5g3p/v2 Version created by Cláudia C Mendes. License: Creative Commons Attribution (CC BY). Faithful Chinese translation; English retains the native procedure. Original quantities, step order and materials are retained. · DOI: 10.17504/protocols.io.yxmvm26m5g3p/v2